github.io

22411298

Atanu Bhattacharjee,Ph.D (Statistics)

Biography

I worked as Assistant Professor Biostatistics in the Section of Biostatistics, Centre for Cancer Epidemiology, Tata Memorial Centre, Mumbai.I am also an Ajunct Professor of Statistics at Department of Applied Mathematics, Indian Institute of Technology-Dhanbad. I completed by Ph.D in statistics under the supervision of Dr. Dilip C Nath. My research interests include Bayesian inference, longitudinal data analysis, survival analysis, gene expression data analysis.

Ph.D Awarded

  1. Abin Thomas 2021 Ph.D thesis “Modeling of Gene Expression for Cancer Biomarkers using Bayesian Frarmework”.
  2. Jesna Jose 2021 Ph.D thesis “Modelling of missing observations in longitudinal measurements”.
  3. Souvik Banerjee 2021 (Submitted) “Joint models for time-to-event and repeated measurement data”.

    Editorial

    Review Editor of Computation Genomics Previous Associate Editor, British Medical Central-Research Methodology. Plos One, Applied Statistics

Book Publication

1.Atanu Bhattacharjee (2021).Bayesian Approaches in Oncology Using R and OpenBUGS.CRC press.https://www.routledge.com/Bayesian-Approaches-in-Oncology-Using-R-and-OpenBUGS/Bhattacharjee/p/book/9780367350505.

  1. Atanu Bhattacharjee (2013).Bayesian Analysis in Longitudinal Data. Lambert Publication.

    Chapters in Book

    Gaurav Roy, Atanu Bhattacharjee, and Iqra Khan (2020).‘Essentials of Cancer Genomic, Computational Approaches and Precision Medicine. Spinger Verlag, Nature.

3.Special Issue:Biostatistics in Oncology.Volume 3, Issue 4 August 2020 Issue Edited by: Atanu Bhattacharjee, in Cancer Reports. https://onlinelibrary.wiley.com/toc/25738348/2020/3/4

Developed R packages listed in CRAN

(I)https://cran.r-project.org/web/packages/SurvHiDim/index.html

[SurvHiDim.pdf]SurvHiDim_0.1.0.tar.gz

(II)https://cran.r-project.org/web/packages/longit/index.html[longit.pdf]

longit_0.1.0.tar.gz

(III)https://cran.r-project.org/web/packages/SurviMChd/index.html[SurviMChd_0.1.0.pdf]

SurviMChd_0.1.0.tar.gz

(IV) https://cran.r-project.org/web/packages/autohd/index.html

[autohd.pdf]autohd_0.1.0.tar.gz

(V)https://cran.r-project.org/web/packages/highMLR/index.html

highMLR_0.1.0.tar.gz

(VI)https://cran.r-project.org/web/packages/afthd/index.html

afthd_1.1.1.tar.gz

(VII)https://cran.r-project.org/web/packages/MIIPW/index.html

MIIPW_0.1.0.tar.gz

(VIII)https://cran.r-project.org/web/packages/QoLMiss/index.html

QoLMiss_0.1.0.tar.gz

(IX)https://cran.r-project.org/web/packages/designsize/index.html

designsize_0.1.0.tar.gz

Contribution to Science

Complete List of Published Work in My Bibliography: https://www.ncbi.nlm.nih.gov/myncbi/atanu.bhattacharjee.1/bibliography/public/

Research Paper

[2023]

Vijay Patil,a Vanita Noronha,a Nandini Menon,a Vijayalakshmi Mathrudev,a Atanu Bhattacharjee,b,c Kavita Nawale,a Deevyashali Parekh,a Shripad Banavali,a and Kumar Prabhash “Metronomic adjuvant chemotherapy evaluation in locally advanced head and neck cancers post radical chemoradiation–a randomised trial”The Lancet Regional Health - Southeast Asia 2023;: 100162.1-s2.0-S2772368223000227-main.pdf

[2022]

  1. Vijay Maruti Patil,Vanita Noronha,Nandini Menon, Ajay Singh , Sarbani Ghosh-Laskar, Ashwini Budrukkar, Atanu Bhattacharjee. “Results of phase 3 randomised trial for use of docetaxel as a radiosensitizer in Head and Neck cancer patients, unsuitable for cisplatin-based chemoradiation”.(Accepted). Journal of Clinical Oncology.Impact Factor 44.54.
  2. Vijay Maruti Patil, Vanita Noronha, Nandini Menon,Rahul Rai,Atanu Bhattacharjee. “Low dose Immunotherapy in Head and Neck cancer - A randomized study”.(Accepted). Journal of Clinical Oncology.Impact Factor 44.54.

  3. Atanu Bhattacharjee,Jishu Dey, Pragya Kumari. A combined iterative sure independence screening and Cox proportion hazard model for extracting and analyzing prognostic biomarkers of adenocarcinoma lung cancer.Healthcare Analytics Available online 13 September 2022, 100108 1-s2.0-S277244252200048X-main.pdf

  4. Vijay Patila,Sravan Kumara ,Vanita Noronha ,Nandini Menona ,Kavita Prakash ,Nawaea MitaliA, Gopi chand Waratkara, Sachin Dhumal ,Atanu Bhattacharjee ,Kumar Prabhash . Long term outcomes of a randomized controlled clinical trial comparing the efficacy of Cabazitaxel versus docetaxel as second-line or above therapy in recurrent head and neck cancer 1-s2.0-S1368837522003748-main.pdf

  5. AtanuBhattacharjeeaGajendra K.VishwakarmaabSouvikBanerjeebSeng HuatOng. A modified risk detection approach of biomarkers by frailty effect on multiple time to event data.Journal of Computational and Applied Mathematics.https://doi.org/10.1016/j.cam.2022.114681

  6. Atanu BhattacharjeeGajendra K. VishwakarmaSouvik BanerjeeAlexander F. Pashchenko. highMLR: An open-source package for R with machine learning for feature selection in high dimensional cancer clinical genome time to event data.https://doi.org/10.1016/j.eswa.2022.118432.Expert Systems with Applications Volume 210, 30 December 2022, 118432.1-s2.0-S0957417422015329-main.pdf

  7. Atanu Bhattacharjee,Gajendra K. Vishwakarma,Namrata Gajare,Neha Singh. Time series analysis using different forecast methods and case fatality rate for COVID-19 pandemic. https://doi.org/10.1111/rsp3.12555Regional Science Policy and Practice.Region Sci Policy Practice - 2022 - Bhattacharjee - Time Series Analysis Using Different Forecast Methods and Case Fatality.pdf

  8. Vijay Patil, Vanita Noronha, Amit Joshi, Nandini Menon, Vijayalakshmi Mathrudev , Atanu Bhattacharjee et al.(2022)RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation 1-s2.0-S1368837522001051-main.pdf
  9. Nandini S. Menon,Vanita Noronha,Vijay Maruti Patil,Amit Joshi, Atanu Bhattacharjee, Devanshi Kalra, Sarbani Ghosh Laskar, Vijayalakshmi Mathrudev,Kavita Nawale,Arati S. Bhelekar,Kumar PrabhashQuality of Life in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Undergoing Concurrent Chemoradiation with Once-a-Week versus Once-Every-3-Weeks Cisplatin.Cancer Medicine - 2022 - Menon - Quality of life in patients with locally advanced head and neck squamous cell carcinoma.pdf

10.Nikita Singh, Mukesh Kumar,Atanu Bhattacharjee, Prashant Kumar Sonker and Agni Saroj. Identification of Biomarkers and Enriched Pathways Involved in Lung Cancer using Statistical Techniques. paper mukesh.pdf

11.Abhishek Mahajan,Navnath Dhone,Richa Vaish, Ankita Singhania, Akshat Malik, Kumar Prabhash, Ankita Ahuja, Nilesh Sable, Pankaj Chaturvedi, Vanita Noronha, Sarbani Gosh Laskar, Ujjwal Agarwal, Shreya Shukla, Gouri Pantvaidya, Prathamesh Pai, Atanu Bhattacharjee, Vijay Patil, Asawari Patil, Munita Bal, Swapnil Rane, Shivakumar Thiagarajan and Anil D’ Cruz(2022).Prognostic Impact of Pattern of Mandibular Involvement in Gingivo-Buccal Complex Squamous Cell Carcinomas: Marrow and Mandibular Canal Staging System. Frontiers in Oncology.fonc-11-752018.pdf

  1. Seema SandeepRedekarab . Satishkumar L. Varmaa, Atanu Bhattacharjee.(2022).Identification of key genes associated with survival of glioblastoma multiforme using integrated analysis of TCGA datasets.Computer Methods and Programs in Biomedicine updates. 1-s2.0-S2666990022000039-main (1).pdf

  2. Gajendra K Vishwakarma, Pragya Kumari, Atanu Bhattacharjee. Thresholding of prominent biomarkers of breast cancer on overall survival using classification and regression tree.Cancer Biomark.2021 Dec 28. doi: 10.3233/CBM-210470.

  3. Akash Pawar, Oindrila Roy Chowdhury, Ruby Chauhan ,Sanjay Talole and Atanu Bhattacharjee. Identification of key gene signatures for the overall survival of ovarian cancer.Journal of Ovarian Cancer. s13048-022-00942-0.pdf.

  4. Gajendra K. Vishwakarma, Atanu Bhattacharjee, Neelesh Kumar. Missing data handling technique in joint modeling context.Biomedical Engineering Advances Volume 2, December 2021, 100012.1-s2.0-S2667099221000128-main (1).pdf

[2021]

1.Nandini Menon, Vijay Patil, Vanita Noronha, Amit Joshi, Atanu Bhattacharjee, Balajirao JSatam, Vijaya lakshmi Mathrudev, Sarbani Ghosh Laskar,Kumar Prabhash. Quality of life in patients with locally advanced head and neck cancer treated with concurrent chemoradiation with cisplatin and nimotuzumab versus cisplatin alone – Additional data from a phase 3 trial.1-s2.0-S1368837521006230-main.pdf

  1. Amit Joshi, Vijay Maruti Patil1, Vanita Noronha, Atanu Bhattacharjee, Nandini Menon, Amit Kumar,Parmanand Jain, Sadaf Mukadam, Avadhoot Shrinivas, Anjali Punia, Anuja Abhyankar, Amit Agarwal, Satvik Khaddar, Anu Rajpurohit, Kanteti Aditya Pavan Kumar, Rahul Ravind, Kishore Das, Vikas Talreja, Sachin Dhumal and Kumar Prabhash. Diclofenac versus tramadol for mucositis related pain in head and neck cancer patients undergoing concurrent chemoradiation – a phase 3 study.ecancermedicalscience-2021-article-1318.pdf

  2. Gajendra K. VISHWAKARMA,Atanu BHATTACHARJEE, Sharvari SHUKLAdTürkiye. COVID-19 Mortality Prediction:An Algorithm by Bayesian Autoregressive Model.Klinikleri Biyoistatistik Dergisi.Turkiye Klinikleri J Biostat. 2021;13(2):178-84.DOI: 10.5336/biostatic.2020-80264.biyoistatistik13-2-6.pdf

4.Ashwini Kalshetty, Biju Menon, Sutapa Rakshit, Atanu Bhattacharjee and Sandip Basu. Correlation of lesional uptake parameters and ratios with miPSMA score and estimating normal physiological concentration: an exploratory analysis in mCRPC patients with 68Ga-PSMA-11 PET-CT. Journal of Nuclear Medicine Technology July 2021, jnmt.120.261289; DOI: https://doi.org/10.2967/jnmt.120.261289.

  1. Jesna Jose,Gajendra K.Vishwakarma, AtanuBhattacharjee.Illustration of Missing Data Handling Technique Generated from Hepatitis C Induced Hepatocellular Carcinoma Cohort Study. Journal of King Saud University - Science,Available online 26 March 2021, 101403.[1-s2.0-S1018364721000641-main.pdf]1-s2.0-S1018364721000641-main (1).pdf

  2. Sharma PJ, Mahajan A, Rane S, Bhattacharjee A. Assessment of COVID-19 severity using computed tomography imaging: A systematic review and meta-analysis. Cancer Research, Statistics, and Treatment. Cancer Res Stat Treat 2021;4:78-87. CancerResStatTreat4178-3984416_110404.pdf

7.Atanu Bhattacharjee, Arti Hole, Akshat Malik, Aditi Sahu, S P Singh, Atul Deshmukh, Sudhir Nair,Pankaj Chaturvedi,Murali Krishna.Risk prediction by Raman spectroscopy for disease-free survival in oral cancers. Lasers in Medical Science.Lasers Med Sci .2021 Mar 4. doi: 10.1007/s10103-021-03276-3.

8.Effect of Early Palliative Care on Quality of Life of Advanced Head and Neck Cancer Patients: A Phase III Trial.Vijay Maruti Patil, MBBS, MD, DM, Pankaj Singhai, MBBS, MD, Vanita Noronha,Atanu Bhattacharjee, Jayita Deodhar,Naveen Salins,Amit Joshi, Nandini Sharrel Menon,Anuja Abhyankar, Ashwini Khake,Sachin Babanrao Dhumal,Rupali Tambe, Bcom, Mary Ann Muckaden,Kumar Prabhas. JNCI: Journal of the National Cancer Institute, djab020, https://doi.org/10.1093/jnci/djab020.

9.Vedang Murthy, Ganesh Bakshi, Jifmi Jose Manjali, Gagan Prakash, Mahendra Pal, Amit Joshi, Kunal Dholakia, Atanu Bhattacharjee, Sanjay Talole, Abhinav Puppalwar, Shashank Srinivasan,Gitanjali Panigrahi,Rohan Salunkhe,Santosh Menon, Vanita Noronha, Kumar Prabhash, Rahul Krishnatry.Locoregional recurrence after cystectomy in muscle invasive bladder cancer: Implications for adjuvant radiotherapy.Orologic Oncology: Seminar and Original Investigation 000(2021) 1-7.https://doi.org/10.1016/j.urolonc.2021.01.0151-s2.0-S1078143921000156-main.pdf

  1. Gajendra K. Vishwakarmaa,Abin Thomas and Atanu Bhattacharjee.A weight function method for selection of proteins to predict an outcome using protein expression data Journal of Computational and Applied Mathematics.GajendraK.VishwakarmaAbinThomasAtanuBhattacharjee[1,2][3][4][4–6][7][8,9][10][11–14] 1-s2.0-S0377042721000844-main.pdf

  2. Jesna Jose, Hasan M. Al-Dorzi, Awad Al-Omari, Yasser Mandourah, Fahad Al-Hameed, Musharaf Sadat, Eman Al Qasim, Basem Alraddadi, Abdulrahman Al Harthy, Ghaleb A. Al Mekhlafi, Abdullah Almotairi, Kasim Al Khatib, Ahmed Abdulmomen, Ismael Qushmaq, Anees A. Sindi, Ahmed Mady, Othman Solaiman, Rajaa Al-Raddadi, Khalid Maghrabi, Ahmed Ragab, Ayman Kharaba, Sarah Shalhoub, Abdulsalam M. Al-Aithan, Gajendra K. Vishwakarma, Atanu Bhattacharjee, Yaseen M. Arabi .Critically ill patients with diabetes and Middle East respiratory syndrome: a multi-center observational study. s12879-021-05771-y.pdf.

12.Bayesian Competing Risk Analysis: An Application to Nasopharyngeal Carcinoma Patients data( In press)Computational and Systems Oncology.cso2.1006.pdf.Comput Syst Oncol.2020.1:e1006.

[2020]

1.Monika Rajput, Mukesh Kumar, Mayuri Kumari, Atanu Bhattacharjee, Aanchal Anant Awasthi.Identification of key genes and construction of regulatory network for the progression of cervical cancer. gene reports(2020).1-s2.0-S2452014420303794-main.pdf

2.Gajendra K. Vishwakarma,Atanu Bhattacharjee,Souvik Banerjeea.Handling Missingness Value on Jointly Measured Time-Course and Time-to-event Data Handling missingness value on jointly measured time course and time to event data.pdf

3.Vijay PatilVanita NoronhaSachin Babanrao DhumalAmit JoshiNandini MenonAtanu Bhattacharjee and et al. Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial. www.thelancet.com/lancetgh.

4.Atanu Bhattacharjee1,Gajendra K.Vishwakarma,Souvik Banerjee and Sharvari Shukla. Disease progression of cancer patients during COVID-19 pandemic: a comprehensive analytical strategy by timedependent modelling.BMC Medical Research Methodology (2020) 20:209.Bhattacharjee_et_al-2020-BMC_Medical_Research_Methodology.pdf

5.Gajendra K. Vishwakarma,Atanu Bhattacharjee,Souvik Banerjee,Benoit Liquet. Classification Algorithm for High Dimensional Protein Markers in Time-course Data. Accepted in Statistics in Medicine.10.1002@SIM.8720.pdf

6.Atanu Bhattacharjee, Gajendra Vishwakarma and Souvik Banerjee.Joint Modeling of Longitudinal and Time-to-Event Data with Missing Time-Varying Covariates in Targeted Therapy of Oncology.Communications in Statistics: Case Studies, Data Analysis and Applications.Joint modeling PCR.pdf.

7.Atanu Bhattacharjee. Estimation of Treatment Effect with Missing Observations for Three Arms and Three Periods Crossover Clinical Trials.(In Press). Annals of Data Science.https://rdcu.be/b5bPM[ADS.pdf]10.1007_s40745-020-00303-y.pdf

8.Sandip Basu,Atanu Bhattacharjee and Beju Menon. “Standardized Uptake Values and Ratios on 68Ga-DOTATATE PET-CT for Normal organs and Malignant Lesions and their correlation with Krenning Score in patients with Metastatic Neuroendocrine tumors”(In press). Nuclear Medicine Communications.NMC.pdf

9.Hitesh Rajendra Singhavi,Arjun Singh,Atanu Bhattacharjee,Sanjay Talole,Rajesh Dikshit,Pankaj Chaturvedi. Alcohol and Cancer Risk: A Systematic Review and Meta‑Analysis of Prospective Indian Studies.June 2020Indian journal of public health 64(2):186-193 IndianJPublicHealth642186-6212962_171529.pdf

10.Patil, V. M., Noronha, V., Joshi, A., Talreja, V., Dhumal, S., Menon, N., … & Prabhash, K. (2020). Long-term outcomes of locally advanced and borderline resectable esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation treated with neoadjuvant chemotherapy. Cancer Research, Statistics, and Treatment, 3(2), 201.

11.Atanu Bhattacharjee,Mukesh Kumar,Kamalesh Kumar Patel. When COVID-19 will Decline in India? Prediction by Combination of Recovery and Case Load Rate.[CEGH Published.pdf](https://github.com/AtanuBhattacharjee/github.io/files/4840778/CEGH.Published.pdf)

12.Atanu Bhattacharjee,GajendraK.Vishwakarma,Souvik Banerjee and Sharvari Shukla.How to Analyze Cancer Progression in COVID-19 Pandemic? v1_stamped.pdf.

13.Nimisha Tripathi, Sneha Keshari, Pallavi Shahi, Poonam Maurya, Atanu Bhattacharjee, Kushal Gupta, Sanjay Talole, Mekesh Kumar.Human papillomavirus elevated genetic biomarker signature by statistical algorithm.Journal of Cellular Physiology(In press).JCP Published Article.pdf

14.Arun Balaji, Shivakumar Thiagarajan, Harsh Dhar, Akshat Malik, Atanu Bhattacharjee, Adhara Chakraborthy,Snehal Shah, et al.The results of sequential swallowing assessments after total laryngectomy for laryngeal and hypopharyngeal malignancies.European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-020-06105-5 10.1007_s00405-020-06105-5.pdf

15.Nikita Singh,Mukesh Kumar,Atanu Bhattacharjee,Prashant Kumar Sonker,Agni Saroj.Identification of Biomarkers and Enriched Pathways Involved in Lung Cancer. preprints2020NCC.pdf

16.Abin Thomas,Gajendra K.Vishwakarma and Atanu Bhattacharjee.Joint modeling of longitudinal and time-to-event data on multivariate protein biomarkers.https://doi.org/10.1016/j.cam.2020.113016.1-s2.0-S0377042720303071-main.pdf

17.Atanu Bhattacharjee,Subita Patil,Sanjay Talole,Arjun Singh,Pankaj Chaturvedie,Rajesh Dikshit.An impact of single prevalence rate reduction of tobacco on cancer incidence- A challenge for global policy maker.https://doi.org/10.1016/j.cegh.2020.04.029.pagination_CEGH_583.pdf.

18.Vijay M. Patil Arti Bhelekar Nandini Menon Atanu Bhattacharjee Vijai Simha Ram Abhinav Anuja Abhyankar Epari Sridhar Abhishek Mahajan Ameya D. Puranik. Reverse swing‐M, phase 1 study of repurposing mebendazole in recurrent high‐grade glioma.cancer Medicine.https://doi.org/10.1002/cam4.3094.2020I.pdf

19.Atanu Bhattacharjee, Vijay M Patil, Rajesh Dikshit, Kumar Prabhash, Arjun Singh, Pankaj Chaturvedi.Should we wait or not? The preferable option for patients with stage IV oral cancer in COVID-19 pandemic.Head Neck .2020 Jun;42(6):1173-1178. doi: 10.1002/hed.26196. Epub 2020 Apr 28.2020G.pdf

20.Atanu Bhattacharjee, Jacinth Rajendra, Rajesh Dikshit, Shilpee Dutt.HER2 borderline is a negative prognostic factor for primary malignant breast cancer.Breast Cancer Res Treat. 2020 May;181(1):225-231. doi: 10.1007/s10549-020-05608-3.2020F.pdf

21.Atanu Bhattacharjee.Bayesian competing risks analysis without data stratification.DOI:https://doi.org/10.1016/j.cegh.2019.08.010.2020E.pdf

22.Akshat Malik,Sudhir Nair,Arjun Singh,Komal Lamba,Swapnil Rane,Munita Bal,Atanu Bhattacharjee,Hisham Mehanna, Pankaj Chaturvedi.Soft tissue deposit in neck dissection specimen carries a poor prognosis in oral cancer: A matched pair analysis.https://doi.org/10.1002/hed.26103. 2020A.pdf

23.Vanita Noronha,Vijay Maruti Patil,Amit Joshi,Manoj Mahimkar,Usha Patel,Manish Kumar Pandey,Arun Chandrasekharan,Hollis Dsouza,Atanu Bhattacharjee,Abhishek Mahajan,Nilesh Sabale,Jai Prakash Agarwal,Sarbani Ghosh-Laskar,Ashwini Budrukkar,Anil K D’Cruz,Pankaj Chaturvedi ,Prathamesh S Pai,Devendra Chaukar, Sudhir Nair,Shivakumar Thiagarajan,Shripad Banavali,Kumar Prabhash. Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer. Oncotarget . 2020 Jan 28;11(4):399-408. doi: 10.18632/oncotarget.27443.2020B.pdf

24.Vanita Noronha,Atanu Bhattacharjee,Vijay M Patil,Amit Joshi,Nandini Menon,Srushti Shah,Sadhana Kannan,Sadaf A Mukadam, Kamesh Maske, Sandeep Ishi, Kumar Prabhash.Aprepitant for Cough Suppression in Advanced Lung Cancer: A Randomized Trial.Chest . 2020 Jan 18;S0012-3692(20)30032-5. doi: 10.1016/j.chest.2019.11.048.2020C.pdf

25.Vijay Maruti Patil,Vanita Noronha,Shivakumar Thiagarajan,Amit Joshi,Arun Chandrasekharan,Vikas Talreja,Jaiprakash Agarwal,Sarbani Ghosh-Laskar,Ashwini Budrukkar,Shashikant Juvekar,Abhishek Mahajan,Archi Agarwal,Nilendu Purandare,Atanu Bhattacharjee, Anil K D’Cruz, Pankaj Chaturvedi,Prathamesh S Pai 2,Devendra Chaukar,Kumar Prabhash.Salvage surgery in head and neck cancer: Does it improve outcomes?Eur J Surg Oncol. 2020 Jan 15;S0748-7983(20)30024-X. doi: 10.1016/j.ejso.2020.01.019.2020D.pdf

26.Vijay M. Patil, Vanita Noronha, Amit Joshi,Vikas Talreja, Sachin Dhumal, Nandini Menon,Anuja Abhyankar, Hollis Dsouza,Gunjesh Kumar Singh, Atanu Bhattacharjee,Sarbani Ghosh‑Laskar,Prathamesh Pai,Pankaj Chaturvedi,Deepa Nair,Devendra Chaukar3, Anil D’Cruz,Prakash Shetty3, Aliasgar Moiyadi,Kumar Prabhash.Long-term outcomes of locally advanced and borderline resectable esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation treated with neoadjuvant chemotherapy.Cancer Res Stat Treat 2020;3:201-6.2020T.pdf

[2019]

  1. Amit Joshi, Sameer Shrirangwar, Vanita Noronha, Nilesh Sable, Archi Agarwal, Palak Popat, Atanu Bhattacharjee, Kumar Prabhash. A tertiary care audit of using abiraterone acetate in patients of metastatic castrate-resistant prostate cancer. Asian J Cancer 2020;9:23-6.
  2. Thiagarajan S, Dhar H, Bhattacharjee A, Fatehi KS, Shah SB, Chaukar D, Nair D, Deshmukh A, Prabhash K, Joshi A, Patil V, Noronha V, Laskar SG, Cruz AKD.Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to Neo-Adjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis.Oral Oncol. 2019 Nov 15;100:104455. doi: 10.1016/j.oraloncology.2019.104455.
  3. Narasimhan M, Kannan S, Chawade A, Bhattacharjee A, Govekar R. Clinical biomarker discovery by SWATH-MS based label-free quantitative proteomics: impact of criteria for identification of differentiators and data normalization method.J Transl Med. 2019 May 31;17(1):184. doi: 10.1186/s12967-019-1937-9.
  4. Patil V,Joshi A,Noronha V,Agarwala V,Chougule A,Kanan S, Bhattacharjee A, Chandrasekharan A, Pande N, Simha V, Goud S, More S, Kumar R, Mahajan A, Janu A, Purandare N, Prabhash K.Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer.Oncotarget. 2019 Oct 29;10(59):6297-6307. doi: 10.18632/oncotarget.27214. eCollection 2019 Oct 29.

  5. Singhavi HR, Chakrabarti S, Singh A, Mair M, Bhattacharjee A, Shetty R, Qayyumi B, Pai A, Joshi P, Nair D, Nair S, Chaturvedi P.Comparison of the 7th and 8th edition AJCC classification system in oral cavity squamous cell cancers.Int J Cancer. 2019 Oct 3. doi: 10.1002/ijc.32720. 2019M.pdf

  6. Vijay Patil, Vanita Noronha, Amit Joshi, Anuradha Chougule, Atanu Bhattacharjee, Alok Goel, Vikas Talreja, Nandini Menon, Anant Ramaswamy, Ashay Karpe, Nikhil Pande, Arun Chandrasekharan, Abhishek Mahajan, Amit Janu, Nilendu Purandare, Kumar Prabhash. Quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of a Phase III randomized trial to compare the benefit of gefitinib versus pemetrexed/ carboplatin for epidermal growth factor receptor-mutated non-small cell lung cancer.Cancer Research,Statistics and Treatment.2019 2(1).21-27.
  7. Patil VM, Noronha V, Joshi A, Agarwal J, Ghosh-Laskar S, Budrukkar A, Murthy V, Gupta T, Mahimkar M, Juvekar S, Arya S, Mahajan A, Agarwal A, Purandare N,Rangarajan V, Balaji A, Chaudhari SV, Banavali S, Kannan S, Bhattacharjee A, D’Cruz AK, Chaturvedi P, Pai PS, Chaukar D, Pantvaidya G, Nair D, Nair S, Deshmukh A,Thiagarajan S, Mathrudev V, Manjrekar A, Dhumal S, Maske K, Bhelekar AS, Nawale K, Chandrasekharan A, Pande N, Goel A, Talreja V, Simha V, Srinivas S, Swami R,Vallathol DH, Dsouza H, Shrirangwar S,Turkar S, Abraham G, Thanky AH,Patel U,Pandey MK,Prabhash K.A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.Cancer. 2019 Sep 15;125(18):3184-3197. doi: 10.1002/cncr.32179. Epub 2019 May 31.
  8. Noronha V, Patil VM, Joshi A, Menon N, Chougule A, Mahajan A, Janu A, Purandare N, Kumar R, More S, Goud S, Kadam N, Daware N, Bhattacharjee A, Shah S, Yadav A, Trivedi V, Behel V, Dutt A, Banavali SD, Prabhash K.Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer.J Clin Oncol. 2019 Aug 14:JCO1901154. doi: 10.1200/JCO.19.01154.
  9. Bhattacharjee A.Bayesian competing risks analysis without data stratification.Clinical Epidemiology and Global Health (In press) 2019. 10.Mukesh Kumar Prashant Kr. Sonker Agni Saroj Aanchal Jain Atanu Bhattacharjee Rakesh Kr. Saroj. Cancer Reports.Parametric survival analysis using R: Illustration with lung cancer data.2019. https://doi.org/10.1002/cnr2.1210
  10. Bhattacharjee A.A joint longitudinal and survival model for dynamic treatment regimes in Presence of Competing Risk Analysis. Clinical Epidemiology and Global Health.2019.7(3).337-341.

  11. Bhattacharjee A,Budukh A,Dikshit R.Prostate cancer survival estimates: An application with piecewise hazard function derivation.South Asian journal of cancer.2019.8(3).105.SouthAsianJCancer83150-4324212_120042.pdf

  12. A Bhattacharjee, GK Vishwakarma.Time-course data prediction for repeatedly measured gene expression.International Journal of Biomathematics.2019.12(4).bhattacharjee2019.pdf

  13. Vijay M Patil, Arun Chandrasekharan, Dilip Harindran Vallathol, Mridul Malhotra, Ram Abhinav, Priti Agarwal, Anu Rajpurohit, Raees Tonse, Atanu Bhattacharjee, Rakesh Jalali. Antiemetic prophylaxis with temozolomide: an audit from a tertiary care center.2019.Neuro-Oncology Practice.4(19).20200708171912.pdf

  14. Atanu Bhattacharjee, Gaurav Roy, Atul Budukh, Rajesh Dikshit, Vijay M Patil, Amit Joshi, Vanita Noronha, Kumar Prabash, Papai Roy A competing risk analysis of death patterns in male genitourinary cancer.(2019).Cancer Reports, e1174.cnr2.1174.pdf.

16.Vanita Noronha,Vijay Maruti Patil,Amit Joshi,Nandini Menon,Anuradha Chougule,Abhishek Mahajan,Amit Janu,Nilendu Purandare,Rajiv Kumar,Sucheta More,Supriya Goud,Nandkumar Kadam,Nilesh Daware,Atanu Bhattacharjee,Srushti Shah,Akanksha Yadav, Vaishakhi Trivedi, Vichitra Behel,Amit Dutt,hripad Dinanath Banavali,and Kumar Prabhash.Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer.noronha2019.pdf

[2018]

1.Atanu Bhattacharjee,Gajendra K. Vishwakarma,Abin Thomas.Bayesian state-space modeling in gene expression data analysis: An application with biomarker prediction.2018;Mathematical Biosciences.2018 Nov;305:96-101. doi: 10.1016/j.mbs.2018.08.011. Epub 2018 Sep 5.2018A.pdf

2.Vijay Patil, Amit Joshi, Vanita Noronha, Atanu Bhattacharjee1, Sachin Dhumal, M. V. Chandrakanth, Ashay Karpe, Vikas Talreja, Arun Chandrasekharan, Siddharth Turkar, Nikhil Pande, Anant Ramaswamy, Kumar Prabhash. Quality of life and quality‑adjusted time without toxicity in palliatively treated head‑and‑neck cancer patients.South Asian J Cancer 2018;7:249-53.2018B.pdf.

3.Vanita Noronha,Avinash Pandey,Vijay Patil,Amit Joshi,Anuradha Bharat Choughule,Atanu Bhattacharjee,Rajiv Kumar,Supriya Goud,Sucheta More,Anant Ramaswamy,Ashay Karpe,Nikhil Pande, Arun Chandrasekharan,Alok Goel, Vikas Talreja, Abhishek Mahajan, Amit Janu, Nilendu Purandare, Kumar Prabhash.Tyrosine Kinase Inhibitor versus Physician Choice Chemotherapy in Second‑Line Epidermal Growth Factor Receptor Mutation Non‑Small Cell Lung Cancer: Post hoc Analysis of Randomized Control Trial.Indian Journal of Medical and Paediatric Oncology.2018;39(4).493-498.2018C.pdf.

4.Biju Menon,Atanu Bhattacharjee,Sandip Basu.Comparison of Radioiodine uptake by Gamma Camera and Thyroid uptake probe‐based methodologiesand Diagnostic Radioiodine Scanin Differentiated thyroid carcinoma.J of Nuclear Medicine Technology, doi:10.2967/jnmt.118.207837.2018D.pdf.

5.Vijay M. Patil, Mridul Malhotra, Raees Tonse, Jayita Deodhar, Arun Chandrasekharan, Nikhil Pande, Atanu Bhattacharjee, and Rakesh Jalali.A cross-sectional audit of distress in patients undergoing adjuvant therapy or follow-up in central nervous system malignancies.Neuro-Oncology Practice.Neuro-Oncology Practice, Volume 6, Issue 4, August 2019, Pages 305–310, https://doi.org/10.1093/nop/npy046.2018E.pdf.

6.Patil V, Joshi A, Noronha V, Dhumal S, Chandrasekharan A, Pande N, et al. Quality of life without toxicity or symptoms analysis of a randomized controlled clinical trial comparing efficacy of cabazitaxel versus docetaxel in recurrent head and neck cancer. Cancer Res Stat Treat 2018;1:46-50.2018F.pdf.

7.Bhattacharjee A, Vishwakarma GK, Banerjee S. A Bayesian approach for dynamic treatment regimes in the presence of competing risk analysis. Cancer Res Stat Treat 2018;1:51-7.2018G.pdf.

8.Influence of Hypothyroidism After Chemoradiation on Outcomes in Head and Neck Cancer.Clinical Oncology xxx (2018) 1.2018H.pdf.

9.Atanu Bhattacharjee,Vijay M. Patil,Vanita Noronha,Amit Joshi,Kumar Prabhash.An Algorithm to Define the Optimum Biological Dose of Metronomic Chemotherapy.Biometrical Letters Vol. 0 (2018), No. 0, xx-xx.2018I.pdf.

  1. Nair CK, Raghavan V, Bhattacharjee A, Kurup AR. Impact of early reduction in paraprotein on survival in transplant ineligible myeloma: Lesson from a tertiary cancer center in rural India.2018J.pdf

11.Amit Joshi, Vijay Patil, Vanita Noronha, Anuradha Chougule, Atanu Bhattacharjee, Rajiv Kumar, Supriya Goud, Sucheta More, Anant Ramaswamy, Ashay Karpe, Nikhil Pande, Arun Chandrasekharan, Alok Goel, Vikas Talreja, Abhishek Mahajan, Amit Janu, Nilendu Purandare, Kumar Prabhash: Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?. Lung India 01/2018; 35(1):27., DOI:10.4103/lungindia.lungindia_201_17. 2018K.pdf

12.Gaurav Roy, Papai Roy, Atanu Bhattacharjee, Mudassar Shahid, Mohammad Misbah, Subash Gupta, Mohammad Husain. Expression signature of lysosomal-associated transmembrane protein 4B in hepatitis C virus-induced hepatocellular carcinoma.The International Journal of Biological Markers.2018, Vol. 33(3) 283–292.2018L.pdf

[2017]

1.Joshi A, Tandon N, Patil VM, Noronha V, Gupta S, Bhattacharjee A, et al. Agreement analysis between three different short geriatric screening scales in patients undergoing chemotherapy for solid tumors. J Can Res Ther 2017;13:1023-6.2017A.pdf.

2.Amit Joshia,Vijay Patila,1, Vanita Noronhaa, Sachin Dhumala, Nikhil Pandea,Arun Chandrasekharana, Siddharth Turkara, Hollis DSouzaa, Sameer Shrirangwara,Abhishek Mahajanb, Supreeta Aryab, Shashikant Juvekarb, Atanu BhattaCharjeec,Kumar Prabhasha,⁎Results of a phase II randomized controlled clinical trial comparing efficacyof Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer.Oral Oncology 75 (2017) 54–60.2017B.pdf.

3.Noronha V, Patil VM, Joshi A, Bhattacharjee A, Paul D, Dhumal S, et al. A tertiary care experience with paclitaxel and cetuximab as palliative chemotherapy in platinum sensitive and nonsensitive in head and neck cancers. South Asian J Cancer 2017;6:11-4.2017C.pdf

4.Niranjan Gopal,Bidhan Chandra Koner,Atanu Bhattacharjee,Vishnu Bhat, Sathish Babu,Murugaiyan, Prakash H. Muddegowda.Assay of Urinary Protein Carbonyl Content Can Predict the Steroid Dependence and Resistance in Children with Idiopathic Nephrotic Syndrome.Saudi J Kidney Dis Transpl 2017;28(2):268-2722017D.pdf

5.Atanu Bhattacharjee,Jesna Jose,Gajendra K. Vishwakarma,Ramesh Kumar.Joint modeling of missing and mismeasured measurements for computing radiotherapy margins2017E.pdf

6.Atanu Bhattacharjeea,Tapesh Bhattacharyya,Sanjana Santhosh,P. Kiran,V.P. Sanudev Sadanandan,M. Geetha.Impact of waiting time for treatment on survival in patients undergoing radiotherapy for head and neck cancer.Journal of Cancer Policy 13 (2017) 1–42017F.pdf

7.A. Bhattacharjee, et al., Human epidermal growth factor receptor 2 borderline mortality in breast cancer patients: Evidence from surveillance, epidemiology, and end results program population-based study, Clin Epidemiol Glob Health (2018), https://doi.org/10.1016/j.cegh.2017.12.005.2017G.pdf

8.Joshi A, Bhattacharjee A, Noronha V, Patil V M, Karpe A, Kadam N, Solanki L, Prabhash K. Development and validation of a predictive score, for identifying poor eastern cooperative oncology group performance status (performance status 3–4) advanced nonsmall cell lung cancer patients who are likely to benefit from tyrosine kinase inhibitors.Indian J Cancer 2017;54:127-131.2017H.pdf

9.Vanita Noronha,Vijay Patil1,Amit Joshi1, Anuradha Chougule,Atanu Bhattacharjee,Rajiv Kumar, Sucheta More,Supriya Goud, Ashay Karpe, Anant Ramaswamy, Nikhil Pande, Arun Chandrasekharan, Alok Goel, Vikas Talreja, Abhishek Mahajan, Amit Janu, Nilendu Purandare and Kumar Prabhash.Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed–carboplatin chemotherapy2017I.pdf

10.Joshi A, Patil VM, Noronha V, Ramaswamy A, Gupta S, Bhattacharjee A, et al. EMERALD: Emergency visit audit of patients treated under medical oncology in a tertiary cancer center: Logical steps to decrease the burden. South Asian J Cancer 2017;6:186-9.2017J.pdf

11.Amit Joshi,Vijay Patil,Vanita Noronha,Sachin Dhumal,Nikhil Pande,Arun Chandrasekharan,Siddharth Turkar,Hollis DSouza,Sameer Shrirangwar, Abhishek Mahajan, Supreeta Arya, Shashikant Juvekar, Atanu BhattaCharjee, Kumar Prabhash. Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer.Oral Oncol . 2017 Dec;75:54-60. 2017K.pdf

12.Joshi A, Tandon N, Patil VM, Noronha V, Gupta S, Bhattacharjee A, et al. Agreement analysis between three different short geriatric screening scales in patients undergoing chemotherapy for solid tumors. J Can Res Ther 2017;13:1023-6.2017L.pdf

13.Tapesh Bhattacharyya and Atanu Bhattacharjee.A New Index to Measure Intra-observer Variation in Delineating GTV Primary in Head and Neck Cancer.MOJ Cell Sci Rep. 2017;4(4):104‒108.2017M.pdf

14.Atanu B, Gajendra V, Jesna J and Ramesh V.Multiple Imputations for Determining an Optimum Biological Dose of a Metronomic Chemotherapy.Biostat Biometrics Open Acc J 3(5): BBOAJ.MS.ID.555621 (2017).2017N.pdf

15.Vijay M Patil,Vanita Noronh,Amit Joshi,Kumar Prabhash,Atanu Bhattacharjee.Bayesian relative survival : An illustration with lung cancer patients data.Journal of Statistics & Management Systems Vol. 20 (2017), No. 3, pp. 325–336.2017O.pdf

16.Vanita Noronha, Amit Joshi, Vijay Maruti Patil, Jaiprakash Agarwal, Sarbani Ghosh-Laskar, Ashwini Budrukkar, Vedang Murthy, Tejpal Gupta, Anil K. D’Cruz, Shripad Banavali, Prathamesh S. Pai, Pankaj Chaturvedi, Devendra Chaukar, Nikhil Pande, Arun Chandrasekharan, Vikas Talreja, Dilip Harindran Vallathol, Vijayalakshmi Mathrudev, Aparna Manjrekar, Kamesh Maske, Arati Sanjay Bhelekar, Kavita Nawale, Sadhana Kannan, Vikram Gota, Atanu Bhattacharjee, Shubhada Kane, Shashikant L. Juvekar, and Kumar Prabhash.Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.J Clin Oncol . 2018 Apr 10;36(11):1064-1072.2017P.pdf.

17.Retrospective analysis of palliative metronomic chemotherapy in head and neck cancer.2017Q.pdf

18.Comparison of paclitaxel-cetuximab chemotherapy versus metronomic chemotherapy consisting of methotrexate and celecoxib as palliative chemotherapy in head and neck cancers.

19.Atanu B,Savanur S and Suman K.Risk-Based Monitoring in Clinical Trial: An Application with Neural Networking.Biostat Biometrics Open Acc J 3(5): BBOAJ.MS.ID.555524 (2017).2017S.pdf

20.Atanu Bhattacharjee,Gajendra Vishwakarma,Abin Thomas.Detecting Diagnostic Accuracy of Biomarkers Through a Bivariate Beta Distribution.2017T.pdf

21.A Novel Model to Predict Tumour Recurrence in Hepatitis B Virus Associated Hepatocellular Carcinoma.2017U.pdf

22.Jaiprakash Aggarwal,Santam Chakraborty,Sarbani Ghosh Laskar,Vijay M. Patil,Kumar Prabhash,Atanu Bhattacharjee,Vanita Noronha,Nilendu C. Purandare,Amit Joshi,Naveen Mummudi,Jitendra Arora,Rupali Badhe.Reference Data for Standardized Quality of Life Questionnaires in Indian Patients with Brain Metastases from Non-small Cell Lung Cancer: Results from a Prospective Study.Cureus 9(4): e1149. DOI 10.7759/cureus.11492017V.pdf

24.Vijay Maruti Patil,Vanita Noronha,Amit Joshi,Anuradha Bharat Choughule,Atanu Bhattacharjee,Rajiv Kumar,Supriya Goud,Sucheta More,Anant Ramaswamy,Ashay Karpe,Nikhil Pande,Arun Chandrasekharan,Alok Goel,Vikas Talreja,Abhishek Mahajan,Amit Janu,Nilendu Purandare,Kumar Prabhash.Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma.ESMO Open 2017;2:e000168. doi:10.1136/esmoopen-2017-000168 .2017W.pdf

25.Vijay M. Patil,Vanita Noronha,Amit Joshi,Anant Ramaswamy,Sachin Dhumal,Shashikant Juvekar,Supreeta Arya,Abhishek Mahajan,Pankaj Chaturvedi,Anil D’Cruz,Atanu Bhattacharjee,Kumar Prabhash.Neoadjuvant chemotherapy in geriatric head and neck cancers.HEAD & NECK—DOI 10.1002/HED MONTH 20172017X.pdf

26.Atanu Bhattacharjee,Vijay M Patil.Determining an optimum biological dose of a metronomic chemotherapy.Journal of Data Science 15(2017), 867-884 2017Y.pdf

27.Vijay M Patil, Vanita Noronh, Amit Joshi, Kumar Prabhash & Atanu Bhattacharjee.Bayesian accelerated failure time and its application in Chemotherapy drug treatment trial.Journal of Statistics & Management Systems Vol. 20 (2017), No. 3, pp. 325–336.2017Z.pdf

[2016-2014]

1.VM Patil,S Chakraborty,TK Jithin, S Dessai, TP Sajith Babu,V Raghavan, M Geetha, T Shiva Kumar, MS Biji, A Bhattacharjee, C Nair.Development and validation of a questionnaire to measure preferences and expectations of patients undergoing palliative chemotherapy: EXPECT questionnaire.Indian Journal of Cancer.2016;53(2),339-344.2016A.pdf.

2.SB Dessai,VM Patil,S Chakraborty,S Babu,A Bhattacharjee,S Nayanar,S Vikram, S Balasubramanian.An audit of cytoreductive surgeries in ovarian cancer from a rural based cancer center.Indian Journal of Cancer.2016;53(2),284-287.2016B.pdf.

3.VM Patil,S Chakraborty,TK Jithin,S Dessai,TP Sajith Babu,V Raghavan,M Geetha,T Shiva Kumar,MS Biji,A Bhattacharjee, C Nair.Development and validation of a questionnaire to measure preferences and expectations of patients undergoing palliative chemotherapy: EXPECT questionnaire.Indian Journal of Cancer.2016;53(2),339-344.2016C.pdf.

4.Vijay M. Pati, Vanita Noronha, Amit Joshi, Saurabh Zanwar, Anant Ramaswamy, Supreeta Arya, Abhishek Mahajan, Atanu Bhattacharjee, Kumar Prabhash.Dihydropyrimidine dehydrogenase mutation in neoadjuvant chemotherapy in head and neck cancers: Myth or reality?2016D.pdf.

5.Atanu Bhattacharjee,Vijay M. Patil.Time-Dependent Area Under the ROC Curve for Optimum Biological Dose Detection.Turkiye Klinikleri J Biostat 2016;8(2):103-9.2016E.pdf.

6.SB Dessai, S Chakraborty, TVS Babu, S Nayanar, A Bhattacharjee,J Jones,S Balasubramanian,VM Patil,Tolerance of weekly paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin.Indian Journal of Cancer.2016;53(2),280-283.2016F.pdf.

7.Vijay M. Patil,Vanita Noronha,Amit Joshi,Vamshi Muddu,Sachin Dhumal,Atanu Bhattacharjee,Kumar Prabhash.Compliance With Neoadjuvant Chemotherapy in T4 Oral Cancers:Place, Person, Socioeconomic Status, or Assistance(2015).JGO – Journal of Global Oncology.1(2).2016G.pdf.

8.Vijay Patil,Amit Joshi, Vanita Noronha,Jayita Deodhar,Atanu Bhattacharjee,Sachin Dhumal,M.V.K. Chandrakanth,Ashay Karpe,Vikas Talreja, Arun Chandrasekharan,Siddharth Turkar,Anant Ramaswamy,Kumar Prabhash.Oral Oncology 63 (2016) 10–15.Expectations and preferences for palliative chemotherapy in head and neck cancers patients2016H.pdf.

9.Ramesh K. Vishwakarma,Dilip C. Nath,Atanu Bhattaharjee.Working Correlation Structures:Application in Liver Cirrhosis Therapeutic Effect Trial.Turkiye Klinikleri J Biostat 2016;8(2):116-24.2016I.pdf.

10.Dilip C. Nath, Ramesh K. Vishwakarma, Atanu Bhattacharjee.A selection modelling approach to analysing missing data of liver Cirrhosis patients.Biometrical Letters Vol. 53 (2016), No. 2, 83-1032016J.pdf.

11.Niranjan Gopal,Bidhan Chandra Koner,Atanu Bhattacharjee, Vishnu Bhat.Assay of Urinary Protein-Bound Sialic Acid can Differentiate Steroid-Sensitive Nephrotic Syndrome from Steroid-Resistant Cases.Saudi J Kidney Dis Transpl 2016;27(1):37-40.2016K.pdf

12.Efficacy of second-line erlotinib in patients postprogression of first-line chemotherapy in head and neck cancers.2015;52(4).629-631.2015A.pdf

13.S. Kane,V.M. Patily,A. Joshi,V. Noronha,V. Muddu,S. Dhumal,S. Juvekar,S. Arya,A. D’Cruz,A. Bhattacharjee,K. Prabhash.2015B.pdf

14.Neoadjuvant Chemotherapy in Technically Unresectable Oral Cancers: Does Human Papillomavirus Make a Difference?Clinical Oncology xxx (2015) 1e2.2015C.pdf

15.Dilip C Nath,Atanu Bhattacharjee and Ramesh K Vishwakarma.The Cure Rate Modeling: An Application with Bayesian approach in Liver Cirrhosis Patients.Journal of Data Science 13(2015), 421-442.2015D.pdf

16.Atanu Bhattacharjee,and Tapesh Bhattacharyya.Bayesian Concordance Correlation Coefficient with Application to Repeatedly Measured Data.Turkiye Klinikleri J Biostat 2015;7(2):55-62 2015E.pdf.

17.Atanu Bhattacharjee and Santam Chakraborty.”In regard to Livi et al. “Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5 year survival analysis of a phase 3 randomised controlled trial”.European Journal of Cancer (2015) 51, 1476– 1477.2015F.pdf

18.Atanu BhattacharjeeDistance Correlation Coefficient: An Application with Bayesian Approach in Clinical Data Analysis.Journal of Modern Applied Statistical Methods 2014;13(1):354-366.2014A.pdf

19.Atanu Bhattacharjee, and Subhradev Sen.Letter to the editor: Second, third, and fourth head and neck tumors. A progressive decrease in survival.Head & Neck 36: 1376, 2014.2014B.pdf

20.Atanu Bhattacharjee and Dilip C. Nath.Joint Longitudinal and Survival Data Modeling: An Application inAnti-Diabetes Drug Therapeutic Effect. Statistics in Transition new series.2014;15(3).437-452. 2014C.pdf

[2013-2012]

21.Bhattacharjee Atanu,and Saikia Hemanta.An Application of Bootstrap Regression Method in Age Dependency Structure to the Community. Indian Journal of Public Health Research & Development.2013;4(3).44-48.2013A.pdf

22.Bhattacharjee A, Bhattacharjee D. A Bayesian Approach to Compare the Statewise Dengue Death Counts in India. International Journal of Collaborative Research on Internal Medicine & Public Health. 2011; 3(10):715-723.20200602100511.pdf

23.Dilip C. Nath and Atanu Bhattacharjee. Comparison of the tetrachoric correlation coefficients and odds in generalized estimating equation with Bayesian approach: an application in type 2 diabetes patients data.2011;5(2):97-108. 20200602101224.pdf.

24.Hemanta Saikia,Dibyojyoti Bhattacharjee,and Atanu Bhattacharjee.Is IPL responsible for cricketers’ performance in Twenty20 World Cup? International Journal of Sports Science and Engineering.2012;6(02):096-110.20200602102234.pdf

25.Dilip C. Nath and Atanu Bhattacharjee.Effect of Correlation Structure in Generalized Estimating Equation and Quasi Least Square: An Application in Type 2 Diabetes Patient. Pak.j.stat.oper.res.2011.VII(2).401-412. 20200602102044.pdf

26.A Bayesian Approach for Autoregressive Models in Longitudinal Data Analysis: An Application to Type 2 Diabetes Drug Comparison.20200602101832.pdf

Biostatistics Tutorial

  1. Introduction to Biostatistics 1546938553M1.pdf
  2. Survival Analysis Survival Analysis.pdf
  3. Parametric survival analysis parametric survival analysis.pdf
  4. Acturial estimator with R Acturial estimator with R.pdf
  5. Kaplan Meier Estimators-I Kaplan Meier Estimators-I.pdf
  6. Kaplan Meier Estimators-II Uploading Kaplan Meier Estimators-Ii.pdf…
  7. Nelson aalen estimator nelson aalen estimator.pdf
  8. Equality of survival equality of survival function.pdf
  9. Mantel Haenszel Estimator Mantel-Haenszl Estimators.pdf

  10. Cox PH Model Cox PH model.pdf

  11. Estimation and Inference for Cox’s Estimation and Inference for Cox’s.pdf
  12. Diagnostics for Cox’s PH model Diagnostics for Cox’s PH model.pdf
  13. The Accelerated Failure Time The Accelerated Failure Time.pdf
  14. Competing Risks Model Competing Risks Model.pdf
  15. Clinical Trials Clinical Trials.pdf
  16. Sample size determination sample size determination.pdf
  17. Random Allocation random allocation.pdf
  18. Sequential Clinical Trial-I sequential clinical trial.pdf
  19. Sequential Clinical Trial-II sequential clinical trial II.pdf
  20. Sequential Clinical Trial-III sequential clinical trial III.pdf
  21. Randomize play the winder rule Randomize play the winder rule.pdf
  22. The Play the Winnder Rule The Play the Winnder Rule.pdf
  23. Crossover TrialCrossover trial.pdf
  24. Introduction to EpidemiologyIntroduction to Epidemiology.pdf
  25. Disease FrequencyDisease Frequency-I.pdf
  26. Disease Frequency-IIDisease Frequency-II.pdf
  27. Disease Frequency-IIIDisease Frequency-III.pdf
  28. Observational StudyObservational Study.pdf
  29. Analystical StudyAnalytical Study.pdf
  30. Case Control StudyCase Control Study.pdf
  31. Cohort Study-I Cohort Study -I.pdf
  32. Cohort Study-II Cohort Study-II.pdf
  33. Case Control Study -Icase Control Study -I.pdf
  34. Case Control Study -IICase Control Study II.pdf
  35. Confoundingconfounding.pdf
  36. Stratified AnalysisStratified Analysis.pdf
  37. Matched Analysis-IMatched Analysis-I.pdf
  38. Matched Analysis-IMathced Analysis-II.pdf
  39. Lung Cancer Update 2019 presentation.pdf.
  40. Computational Biostatistics and Survival Analysis Talkcce presentation.pdf.
  41. Hands on Survival Analysis Researchers.(https://github.com/atanustat/biostatonco/files/4710190/AB1011.Hands.on.Survival.Analysis.pdf)

    Contact

    abhattacharjee@actrec.gov.in/atanustat@gmail.com
    Centre for Cancer Epidemiology, Tata Memorial Centre, Navi Mumbai,India